IP Verse

Strawman competitive analysis

Latest oppositions filed by Strawman

Explore patent oppositions filed by Strawman against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 1, 2026
Patent NumberTitleApplicantOpposition Date
EP3434767
Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHASep 29, 2026
EP4458350
Lipid Nanoparticle Compositions And Methods For Mrna DeliveryTRANSLATE BIOSep 24, 2026
EP3974180
Method For Producing A Thermoformed And Press-Hardened Steel Sheet ComponentVOLKSWAGENSep 18, 2026
EP3783027
Method And Compositions For Inducing Differentiation Of Myeloid Derived Suppressor Cell To Treat Cancer And Infectious DiseasesOSE IMMUNOTHERAPEUTICSSep 3, 2026
EP3672684
Electroporation Delivery Systems And Methods Of Using Electroporation Delivery SystemsCARDIAC PACEMAKERSSep 2, 2026
EP4025192
Process For Producing A Tablet Comprising Glp-1 PeptidesNOVO NORDISKSep 2, 2026
EP3449940
Antibody-Containing PreparationCHUGAI SEIYAKU KABUSHIKI KAISHAAug 18, 2026
EP3310340
High Concentration FormulationCASSIOPEAAug 5, 2026
EP3440518
Real Time Monitoring Of Product PurificationBOEHRINGER INGELHEIM RCVAug 5, 2026
EP3917493
Topical Gel Compositions Of NaproxenBAYER HEALTHCAREAug 4, 2026

Latest PTAB cases involving Strawman

Discover the latest PTAB cases involving Strawman, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Strawman with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 1, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
STRAWMAN474 - - -
AMGEN14164811
CHUGAI SEIYAKU KABUSHIKI KAISHA3115 - 1
NOVARTIS12546 - 21